Feature Channels: Heart Disease

Filters close
Released: 24-Jun-2024 5:05 PM EDT
Heart disease model puts cells to work
Washington University in St. Louis

Researchers at Washington University in St. Louis can more effectively study mutations that cause heart disease by putting cells through their paces.

Not for public release

This news release is embargoed until 24-Jun-2024 5:00 PM EDT Released to reporters: 20-Jun-2024 2:00 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 24-Jun-2024 5:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: Activating molecular target reverses multiple hallmarks of aging
20-Jun-2024 10:00 AM EDT
Activating molecular target reverses multiple hallmarks of aging
University of Texas MD Anderson Cancer Center

Researchers at The University of Texas MD Anderson Cancer Center have demonstrated that therapeutically restoring ‘youthful’ levels of a specific subunit of the telomerase enzyme can significantly reduce the signs and symptoms of aging in preclinical models. If these findings are confirmed in clinical studies, there may be therapeutic implications for age-related diseases such as Alzheimer’s, Parkinson’s, heart disease and cancer.

   
Newswise: New, simple test detects rare fatal genetic heart condition
18-Jun-2024 11:30 AM EDT
New, simple test detects rare fatal genetic heart condition
McMaster University

A team of international researchers has revealed a new, simple clinical test to detect Calcium Release Deficiency Syndrome (CRDS), a life-threatening genetic arrhythmia that causes dangerously fast heartbeats and can lead to severe complications such as sudden cardiac arrest and death.

Newswise: Novel Use of Existing Drug Could Significantly Cut Heart Attack Risk
Released: 18-Jun-2024 3:05 PM EDT
Novel Use of Existing Drug Could Significantly Cut Heart Attack Risk
Georgia Institute of Technology

Heart attacks have been the leading cause of death in the U.S. for a century. While most treatments for cardiac events target breaking down blood clots, Georgia Tech researchers have found a way to prevent blood clots from even forming. Dramatically, their drug is shown to completely knock out the formation of blood clots without increasing the risks of bleeds in vivo.

Newswise: 1920_1920-electrophysiology-cedars-sinai-smidt-heart.jpg?10000
Released: 17-Jun-2024 12:05 PM EDT
Explorando un Posible Nuevo Tratamiento de la Taquicardia Ventricular
Cedars-Sinai

Cuando el electrofisiólogo el Dr. Eugenio Cingolani, no está atendiendo a pacientes, suele estar en su laboratorio, investigando tratamientos mejorados para los trastornos del ritmo cardiaco.

Newswise: 1920_electrophysiology-cedars-sinai-smidt-heart.jpg?10000
Released: 17-Jun-2024 11:05 AM EDT
Exploring Potential New Treatment for Ventricular Tachycardia
Cedars-Sinai

When electrophysiologist Eugenio Cingolani, MD, isn’t seeing patients, he can usually be found in his laboratory, investigating improved treatments for heart rhythm disorders.

Newswise: Marsh Foundation gives gift for Breakthrough Heart Health Research at Texas Tech Health El Paso
Released: 14-Jun-2024 1:00 PM EDT
Marsh Foundation gives gift for Breakthrough Heart Health Research at Texas Tech Health El Paso
Texas Tech University Health Sciences Center El Paso

Dr. Okajima's current research is focused on antiplatelet therapy, a cornerstone treatment for preventing heart attacks and strokes in patients with a history of coronary artery disease. By considering a person's genes, doctors may be able to cater better treatments, especially for Hispanic patients.

Released: 12-Jun-2024 12:00 PM EDT
Media Tip Sheet: More Men Considering Weight Loss Drugs
George Washington University

Now that weight loss drugs like Wegovy have been shown to reduce the risk of heart disease and treat sleep apnea, more men are likely to start taking them, according to an analysis by Reuters.​​​​​​​ ...

Newswise: 1920_nieminen1.jpeg?10000
Released: 11-Jun-2024 12:05 PM EDT
New Atrial Fibrillation Treatment Gets Dad His Beat Back
Cedars-Sinai

Everyone knows exhaustion is a rite of passage for new parents, which is why Henric Nieminen ignored the symptoms at first.

Newswise: New AI Tool Finds Rare Variants Linked to Heart Disease in 17 Genes
10-Jun-2024 5:00 AM EDT
New AI Tool Finds Rare Variants Linked to Heart Disease in 17 Genes
Mount Sinai Health System

Using an advanced artificial intelligence tool, researchers at the Icahn School of Medicine at Mount Sinai have identified rare coding variants in 17 genes that shed light on the molecular basis of coronary artery disease (CAD), the leading cause of morbidity and mortality worldwide. The discoveries, detailed in the June 11 online issue of Nature Genetics, reveal genetic factors impacting heart disease that open new avenues for targeted treatments and personalized approaches to cardiovascular care. The investigators used an in silico, or computer-derived, score for coronary artery disease (ISCAD) that holistically represents CAD, as described in a previous paper by the team in The Lancet. The ISCAD score incorporates hundreds of different clinical features from the electronic health record, including vital signs, laboratory test results, medications, symptoms, and diagnoses. To build the score, they trained machine learning models on the electronic health records of 604,914 individuals

Not for public release

This news release is embargoed until 10-Jun-2024 5:00 PM EDT Released to reporters: 4-Jun-2024 2:00 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 10-Jun-2024 5:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: Intervention Aims to Improve Cardiovascular Health for South Asian Populations
Released: 10-Jun-2024 11:05 AM EDT
Intervention Aims to Improve Cardiovascular Health for South Asian Populations
University of Utah Health

People from South Asian countries tend to develop heart disease 10 years earlier than other populations. Kevin Shah, MD, is working to change that.

Newswise: Valentin Fuster, MD, PhD, Received 2024 Distinguished Award From European Society for Clinical Investigation (ESCI)
Released: 10-Jun-2024 7:00 AM EDT
Valentin Fuster, MD, PhD, Received 2024 Distinguished Award From European Society for Clinical Investigation (ESCI)
Mount Sinai Health System

President of Mount Sinai Fuster Heart Hospital given top honor for his scientific excellence and successful global education initiatives on cardiovascular disease

Newswise: UTSW studies clarify link between exercise, risk of heart disease
Released: 6-Jun-2024 11:05 AM EDT
UTSW studies clarify link between exercise, risk of heart disease
UT Southwestern Medical Center

Exercising at a high level doesn’t affect the progression of calcium buildup in the arteries, even among older athletes such as marathoners who tend to have higher coronary artery calcium (CAC) scores, according to new research from UT Southwestern Medical Center. But a longer duration of exercise is associated with higher CAC.

Newswise: Cleveland Clinic-Led Study Links Sugar Substitute to Increased Risk of Heart Attack and Stroke
3-Jun-2024 3:05 PM EDT
Cleveland Clinic-Led Study Links Sugar Substitute to Increased Risk of Heart Attack and Stroke
Cleveland Clinic

 Cleveland Clinic researchers found higher amounts of the sugar alcohol xylitol are associated with increased risk of cardiovascular events like heart attack and stroke.

Newswise: Study reveals how 'forever chemicals' may impact heart health in older women
Released: 5-Jun-2024 10:05 AM EDT
Study reveals how 'forever chemicals' may impact heart health in older women
College of Agricultural, Consumer and Environmental Sciences, University of Illinois Urbana-Champaign

New research from the University of Illinois Urbana-Champaign has linked multiple types of per- and polyfluoroalkyl substances (PFAS, also known as “forever chemicals”) with increased risk of cardiovascular diseases in postmenopausal women. Specifically, the study reveals how PFAS chemicals interact with pro-inflammatory pathways in older women, providing potential explanations for the increased risk.



close
2.94917